Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
0.00 | 0.00 | 0.00 | 0.00 | ― | Gross Profit |
-121.67K | -117.68K | -85.52K | -54.29K | ― | EBIT |
-10.49M | -7.89M | -5.77M | -2.69M | -1.87M | EBITDA |
-10.62M | -8.51M | -5.68M | -2.66M | -1.72M | Net Income Common Stockholders |
-10.75M | -8.63M | -5.73M | -2.60M | -1.66M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
10.83M | 10.06M | 15.81M | 6.66M | 1.06M | Total Assets |
13.26M | 12.54M | 19.33M | 9.96M | 4.36M | Total Debt |
74.21K | 146.03K | 177.27K | 99.29K | 65.24K | Net Debt |
-10.76M | -9.91M | -15.63M | -6.56M | -997.73K | Total Liabilities |
1.48M | 1.02M | 838.59K | 429.54K | 435.00K | Stockholders Equity |
11.78M | 11.52M | 18.49M | 9.53M | 3.92M |
Cash Flow | Free Cash Flow | |||
-9.31M | -5.90M | -4.49M | -2.40M | -1.75M | Operating Cash Flow |
-9.24M | -5.83M | -4.38M | -2.33M | -1.45M | Investing Cash Flow |
-73.79K | -74.52K | -137.62K | -61.28K | -302.25K | Financing Cash Flow |
10.09M | 158.86K | 13.67M | 7.99M | 2.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
56 Neutral | $6.99B | 3.72 | -4.39% | 5.96% | -0.24% | -48.44% | |
52 Neutral | $1.49B | 22.85 | -4.52% | ― | ― | -127.09% | |
45 Neutral | AU$120.08M | ― | -5.22% | ― | ― | ― | |
45 Neutral | $2.48B | 28.42 | -1.76% | ― | ― | -119.85% | |
45 Neutral | $1.15B | ― | -1.42% | ― | -97.09% | 49.32% | |
34 Underperform | AU$810.79M | ― | ― | ― | 88.27% | ||
29 Underperform | AU$104.12M | ― | -60.48% | ― | ― | -49.15% |
Elevate Uranium Ltd announced progress on its U-pgrade™ Demonstration Plant, which is on track for completion by mid-2025. This plant aims to validate the company’s beneficiation process, with potential implications for future commercial operations. Concurrently, extensive drilling activities at the Koppies Uranium Project are ongoing, with significant resource growth expected to enhance the project’s viability. The appointment of Scott Perry as Non-Executive Chairman and a 12% increase in the Bigrlyi Mineral Resource further bolster the company’s strategic positioning in the uranium market.
Elevate Uranium Ltd has issued a clarification regarding the JORC compliance of ore samples used in developing its U-pgradeTM beneficiation process. This process significantly enhances the concentration of uranium ore from the Marenica Uranium Project in Namibia, increasing the ore grade from 93 ppm U3O8 to over 5,000 ppm U3O8. The announcement confirms the validity of previously reported outcomes and underscores the company’s commitment to innovation in processing low-grade uranium resources, potentially strengthening its position in the global uranium market.
Elevate Uranium Limited has announced the appointment of Scott Perry as a new director, effective March 27, 2025. This appointment is a strategic move for the company, potentially strengthening its leadership team and enhancing its operations in the uranium market. The announcement does not indicate any immediate changes to Perry’s financial interests in the company, as he currently holds no securities or contracts related to Elevate Uranium.
Elevate Uranium Ltd has appointed Scott Perry as the new Chairman, succeeding Andrew Bantock. Perry’s extensive experience in the mining sector, including transforming Centerra Gold into a C$3 billion company, is expected to significantly benefit Elevate Uranium as it progresses its Koppies Uranium Project and U-pgradeTM plant. The company is well-positioned for strategic growth, with strong funding and leadership in place.
Elevate Uranium Ltd announced progress on its U-pgrade™ Demonstration Plant, which is set to be completed by mid-2025. The plant, constructed by Fremantle Metallurgy Pty Ltd, will test the U-pgrade™ beneficiation process to concentrate uranium mineral efficiently, potentially leading to a full-scale commercial plant. Concurrently, resource growth drilling at the Koppies Uranium Project’s Namib IV site continues, which could enhance the project’s resource base and extend its mine life.
Elevate Uranium Ltd has released its half-year financial report for the period ending December 31, 2024. The report includes various financial statements such as the consolidated statement of profit or loss, financial position, changes in equity, and cash flows, along with notes and an independent auditor’s review. This financial disclosure provides stakeholders with insights into the company’s financial health and operational performance over the past six months, which can impact investor confidence and market positioning.
Cumulus Wealth Pty Ltd has become a substantial shareholder in Elevate Uranium Ltd, holding a 5.27% voting power through managed discretionary account services. This development signifies a notable investment in Elevate Uranium, potentially impacting its market position and stakeholder interests by aligning with a significant financial entity.
Elevate Uranium Ltd has announced a 12% increase in the mineral resource estimate for the Bigrlyi Uranium Project, following recent drilling results. This update brings the total uranium content to 10.9kt U3O8, with 20% of the resource now classified as Measured, enhancing geological confidence. The increase in resources strengthens Elevate Uranium’s position in the uranium market and highlights the potential for further growth through ongoing exploration efforts.
Elevate Uranium Ltd is focused on developing globally significant uranium resources, with a dedicated portfolio that includes multiple high-grade prospects in Namibia and Australia. The company has made four significant discoveries in four years, with a total of 160 million pounds of uranium resources globally. This announcement underscores the company’s strong position in the uranium industry and its potential to enhance its market presence, benefiting stakeholders and contributing to the industry’s resource supply.